UHPLC-ESI-ORBITRAP-MS analysis of the native Mapuche medicinal plant palo negro (Leptocarpha rivularis DC.–Asteraceae) and evaluation of its antioxidant and cholinesterase inhibitory properties

dc.contributor.authorJiménez-González, A.
dc.contributor.authorQuispe, C.
dc.contributor.authorBórquez, J.
dc.contributor.authorSepúlveda, B.
dc.contributor.authorRiveros, F.
dc.contributor.authorAreche, C.
dc.contributor.authorNagles, E.
dc.contributor.authorGarcía-Beltrán, O.
dc.contributor.authorSimirgiotis, M.J.
dc.date.accessioned2019-05-28T15:20:49Z
dc.date.available2019-05-28T15:20:49Z
dc.date.issued2018-01
dc.descriptionIndexación: Scopus.es_ES
dc.description.abstractUHPLC/ESI/MS identification of organic compounds is the first step in the majority of screening techniques for the characterization of biologically active metabolites in natural sources. This paper describes a method for the fast identification and characterisation of secondary metabolites in Leptocarpha rivularis DC. (Palo negro) extracts by HPLC/UV (DAD)–Mass Spectrometry (HPLC/MS). The plant is used for the treatment of several diseases since pre-hispanic Mapuche times. Thirty-seven compounds were detected in the aqueous edible extract for the first time including 4 sesquiterpenes, 10 flavonoids, 9 oxylipins, 2 organic acids, and 11 phenolic acids. In addition, phenolic content antioxidant and cholinesterase inhibitory activities were measured for the first time using the edible infusion. The total polyphenol content of the infusion was 230.76 ± 2.5 mmol GAE/kg dry weight, while the antioxidant activity was 176.51 ± 28.84; 195.28 ± 4.83; and 223.92 ± 2.95 mmol TE/kg dry weight, for the DPPH, ABTS, and FRAP assays, respectively. The cholinesterase inhibitory activity was 7.38 ± 0.03 and 5.74 ± 0.06 mmol GALAE/kg, for the inhibition of acetylcholinesterase AChE and BChE, respectively, showing that this plant is a candidate for the isolation of compounds that can be useful for the treatment of neurodegenerative diseases. Furthermore, this plant could serve also as a raw material for the production of dietary supplements, due to its content of polyphenolic compounds. © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.es_ES
dc.description.urihttps://www.tandfonline.com/doi/full/10.1080/14756366.2018.1466880
dc.identifier.citationJournal of Enzyme Inhibition and Medicinal Chemistry, 33(1), pp. 936-944es_ES
dc.identifier.issn1475-6366
dc.identifier.otherDOI: 10.1080/14756366.2018.1466880
dc.identifier.urihttp://repositorio.unab.cl/xmlui/handle/ria/8918
dc.language.isoenes_ES
dc.publisherTaylor and Francises_ES
dc.subjectAntioxidantses_ES
dc.subjectElectrosprayes_ES
dc.subjectLeptocarpha rivularises_ES
dc.subjectMetabolomicses_ES
dc.subjectOrbitrapes_ES
dc.titleUHPLC-ESI-ORBITRAP-MS analysis of the native Mapuche medicinal plant palo negro (Leptocarpha rivularis DC.–Asteraceae) and evaluation of its antioxidant and cholinesterase inhibitory propertieses_ES
dc.typeArtículoes_ES
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Jimenez-Gonzalez_UHPLC_ESI_ORBITRAP_MS.pdf
Tamaño:
2.06 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLES
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: